{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06342310",
            "orgStudyIdInfo": {
                "id": "RE104-201-PPD"
            },
            "organization": {
                "fullName": "Reunion Neuroscience Inc",
                "class": "INDUSTRY"
            },
            "briefTitle": "RE104 Safety and Efficacy Study in Postpartum Depression",
            "officialTitle": "A Multicenter, Randomized, Double-Blind, Parallel-Group Dose-Controlled Study Evaluating the Safety and Efficacy of RE104 for Injection in the Treatment of Patients With Postpartum Depression (PPD)",
            "therapeuticArea": [
                "Mental Health"
            ],
            "study": "safety-and-efficacy-study-in-postpartum-depression"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-06-14",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-05",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-06",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-03-26",
            "studyFirstSubmitQcDate": "2024-03-26",
            "studyFirstPostDateStruct": {
                "date": "2024-04-02",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-23",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-25",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Reunion Neuroscience Inc",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to determine if treatment with a single dose of RE104 for Injection reduces depressive symptoms in participants with moderate-to-severe postpartum depression (PPD) as compared to active-placebo."
        },
        "conditionsModule": {
            "conditions": [
                "Postpartum Depression"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "TRIPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 72,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "1.5 mg RE104",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "A single subcutaneous injection of 1.5 mg RE104 for Injection",
                    "interventionNames": [
                        "Drug: RE104 for Injection"
                    ]
                },
                {
                    "label": "30 mg RE104",
                    "type": "EXPERIMENTAL",
                    "description": "A single subcutaneous injection of 30 mg RE104 for Injection",
                    "interventionNames": [
                        "Drug: RE104 for Injection"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "RE104 for Injection",
                    "description": "Single, subcutaneous dose of RE104 for Injection",
                    "armGroupLabels": [
                        "1.5 mg RE104",
                        "30 mg RE104"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "RE104 30 mg versus RE104 1.5 mg change from baseline in MADRS total score",
                    "description": "Montgomery-\u00c5sberg Depression Rating Scale (MADRS) is a 10-item clinician rated scale measuring depression severity. The total score ranges from 0-60 with higher scores representing greater severity of depression.",
                    "timeFrame": "Day 7"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "RE104 30 mg versus RE104 1.5 mg change from baseline in MADRS total score",
                    "description": "Montgomery-\u00c5sberg Depression Rating Scale (MADRS) is a 10-item clinician rated scale measuring depression severity. The total score ranges from 0-60 with higher scores representing greater severity of depression.",
                    "timeFrame": "Day 1, Day 14 and Day 28"
                },
                {
                    "measure": "RE104 30 mg versus RE104 1.5 mg percentage of patients with MADRS response (\u2265 50 percent reduction in score from baseline)",
                    "description": "Montgomery-\u00c5sberg Depression Rating Scale (MADRS) is a 10-item clinician rated scale measuring depression severity. The total score ranges from 0-60 with higher scores representing greater severity of depression.",
                    "timeFrame": "Day 7"
                },
                {
                    "measure": "RE104 30 mg versus RE104 1.5 mg percentage of patients with MADRS remission (score \u2264 to 10)",
                    "description": "Montgomery-\u00c5sberg Depression Rating Scale (MADRS) is a 10-item clinician rated scale measuring depression severity. The total score ranges from 0-60 with higher scores representing greater severity of depression.",
                    "timeFrame": "Day 7"
                },
                {
                    "measure": "RE104 30 mg versus RE104 1.5 mg Clinical Global Impression-Improvement (CGI-I)",
                    "description": "The Clinical Global Impression - Improvement (CGI-I) Scale is a clinician-rated instrument that weighs the clinical impact of the identified symptom(s) on behavior and function and measures changes in psychopathology since the treatment was administered on a scale from 1 (very much improved) to 7 (very much worse).",
                    "timeFrame": "Day 1, Day 7 and Day 28"
                },
                {
                    "measure": "RE104 30 mg versus RE104 1.5 mg change from baseline in CGI-Severity (CGI-S)",
                    "description": "The Clinical Global Impression - Severity Scale is a clinician-rated instrument that grades severity of symptoms on a scale from 1 (normal, not ill at all) to 7 (among the most extremely ill patients).",
                    "timeFrame": "Day 1, Day 7 and Day 28"
                },
                {
                    "measure": "RE104 30 mg versus RE104 1.5 mg changes in total score from baseline in Hamilton Anxiety Rating Scale (HAM-A)",
                    "description": "The Hamilton Rating Scale for Anxiety (HAM-A) is a 14-item scale that is used to rate the severity of symptoms of anxiety. The total score ranges from 0-56 with higher scores representing greater severity of anxiety.",
                    "timeFrame": "Day 7"
                },
                {
                    "measure": "RE104 30 mg versus RE104 1.5 mg incidence of treatment-emergent adverse events (TEAEs) by frequency, severity and seriousness.",
                    "description": "A treatment-emergent adverse event (TEAE) is defined as any unfavorable and unintended sign, symptom or disease temporally associated with the use of a study drug.",
                    "timeFrame": "From dosing through study completion (post-dose follow-up is for 28 days)"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Is \u226412 months postpartum at Screening.\n* Meet DSM-5 criteria for postpartum depression (PPD): experiencing a major depressive episode that began at any time starting at the beginning of the second trimester (\u226514 weeks) of pregnancy through 4 weeks post delivery.\n* Has a Hamilton Depression Scale (HAM-D) total score meeting severity threshold at Screening and Baseline.\n* Is not using any psychotropic medications or psychotherapy for 30 days prior to Screening, OR are on an already stable/established regimen of SSRIs or psychotherapy for 30 days prior to Screening.\n* Has ceased breastfeeding at Screening.\n* Has a negative pregnancy test at Screening and Day 0 prior to study drug administration.\n\nExclusion Criteria:\n\n* History or active postpartum psychosis per Investigator assessment.\n* History of treatment-resistant depression within the current postpartum depressive episode.\n* Has a significant risk of suicide.\n* Active or medical history of bipolar disorder, schizophrenia, schizoaffective disorder, psychotic disorder and/or borderline personality disorder, or first-degree family history of psychosis or bipolar disorder.\n* Medically significant condition rendering unsuitability for the study .\n* Has received electroconvulsive therapy (ECT) or transcranial magnetic stimulation within 90 days prior to Screening.\n* Has used psychedelics such as psilocybin, ayahuasca, mescaline, or LSD (with the exception of cannabis) within 12 months prior to Screening.\n* Has used or will need to use prohibited medications.",
            "healthyVolunteers": false,
            "sex": "FEMALE",
            "minimumAge": "18 Years",
            "maximumAge": "45 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Jasna Hocevar-Trnka, M.D.",
                    "role": "CONTACT",
                    "phone": "1-888-880-REUN",
                    "email": "info@reunionneuro.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Jasna Hocevar-Trnka, M.D.",
                    "affiliation": "Reunion Neuroscience Inc",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Reunion Investigational Site",
                    "status": "RECRUITING",
                    "city": "Lauderhill",
                    "state": "Florida",
                    "zip": "33319",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "email": "info@reunionneuro.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 26.14036,
                        "lon": -80.21338
                    }
                },
                {
                    "facility": "Reunion Investigational Site",
                    "status": "RECRUITING",
                    "city": "Atlanta",
                    "state": "Georgia",
                    "zip": "30331",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "email": "info@reunionneuro.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.749,
                        "lon": -84.38798
                    }
                },
                {
                    "facility": "Reunion Investigational Site",
                    "status": "RECRUITING",
                    "city": "Decatur",
                    "state": "Georgia",
                    "zip": "30030",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "email": "info@reunionneuro.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.77483,
                        "lon": -84.29631
                    }
                },
                {
                    "facility": "Reunion Investigational Site",
                    "status": "RECRUITING",
                    "city": "Savannah",
                    "state": "Georgia",
                    "zip": "31405",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "email": "info@reunionneuro.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.08354,
                        "lon": -81.09983
                    }
                },
                {
                    "facility": "Reunion Investigational Site",
                    "status": "RECRUITING",
                    "city": "Honolulu",
                    "state": "Hawaii",
                    "zip": "96817",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "email": "info@reunionneuro.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 21.30694,
                        "lon": -157.85833
                    }
                },
                {
                    "facility": "Reunion Investigational Site",
                    "status": "RECRUITING",
                    "city": "Springfield",
                    "state": "Massachusetts",
                    "zip": "01103",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "email": "info@reunionneuro.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.10148,
                        "lon": -72.58981
                    }
                },
                {
                    "facility": "Reunion Investigational Site",
                    "status": "RECRUITING",
                    "city": "Albuquerque",
                    "state": "New Mexico",
                    "zip": "87131",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "email": "info@reunionneuro.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.08449,
                        "lon": -106.65114
                    }
                },
                {
                    "facility": "Reunion Investigational Site",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10026",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "email": "info@reunionneuro.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Reunion Investigational Site",
                    "status": "RECRUITING",
                    "city": "West Chester",
                    "state": "Pennsylvania",
                    "zip": "19380",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "email": "info@reunionneuro.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.96097,
                        "lon": -75.60804
                    }
                },
                {
                    "facility": "Reunion Investigational Site",
                    "status": "RECRUITING",
                    "city": "San Antonio",
                    "state": "Texas",
                    "zip": "78229",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "email": "info@reunionneuro.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.42412,
                        "lon": -98.49363
                    }
                },
                {
                    "facility": "Reunion Investigational Site",
                    "status": "RECRUITING",
                    "city": "Draper",
                    "state": "Utah",
                    "zip": "84020",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "email": "info@reunionneuro.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.52467,
                        "lon": -111.86382
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO",
            "description": "Data sharing will be consistent with the results submission policy of ClinicalTrials.gov."
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000019052",
                    "term": "Depression, Postpartum"
                },
                {
                    "id": "D000003863",
                    "term": "Depression"
                },
                {
                    "id": "D000003866",
                    "term": "Depressive Disorder"
                }
            ],
            "ancestors": [
                {
                    "id": "D000001526",
                    "term": "Behavioral Symptoms"
                },
                {
                    "id": "D000019964",
                    "term": "Mood Disorders"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                },
                {
                    "id": "D000011644",
                    "term": "Puerperal Disorders"
                },
                {
                    "id": "D000011248",
                    "term": "Pregnancy Complications"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M7058",
                    "name": "Depression",
                    "asFound": "Depression",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7061",
                    "name": "Depressive Disorder",
                    "asFound": "Depression",
                    "relevance": "HIGH"
                },
                {
                    "id": "M21076",
                    "name": "Depression, Postpartum",
                    "asFound": "Postpartum Depression",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4818",
                    "name": "Behavioral Symptoms",
                    "relevance": "LOW"
                },
                {
                    "id": "M21835",
                    "name": "Mood Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14499",
                    "name": "Puerperal Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                }
            ]
        }
    },
    "hasResults": false
}